R. N. Balapadang and H. Sudarjat, “Potential of Beta-Hydroxybutyrate (BHB) in the Management of Type 2 Diabetes and Risk of Ketoacidosis in Diabetic Patients”, JPS, vol. 7, no. 4, pp. 562–570, Oct. 2024.